Genetic, structural and clinical analysis of spastic paraplegia 4.

[1]  X. Montalban,et al.  The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history. , 2020, Brain : a journal of neurology.

[2]  T. Counihan,et al.  Co-incident primary progressive multiple sclerosis and hereditary spastic paraplegia (SPG4) - a case report. , 2020, Multiple sclerosis and related disorders.

[3]  J. Santos-Guzmán,et al.  Clinical Characterization of 2 Siblings with a Homozygous SPAST Variant , 2020, The American journal of case reports.

[4]  E. Brilstra,et al.  De novo SPAST mutations may cause a complex SPG4 phenotype. , 2019, Brain : a journal of neurology.

[5]  G. Lander,et al.  An allosteric network in spastin couples multiple activities required for microtubule severing , 2019, Nature Structural & Molecular Biology.

[6]  G. Stevanin,et al.  Update on the Genetics of Spastic Paraplegias , 2019, Current Neurology and Neuroscience Reports.

[7]  S. Tezenas du Montcel,et al.  Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex , 2018, Brain : a journal of neurology.

[8]  Silvio C. E. Tosatto,et al.  InterPro in 2019: improving coverage, classification and access to protein sequence annotations , 2018, Nucleic Acids Res..

[9]  K. Boycott,et al.  Association of Early-Onset Spasticity and Risk for Cognitive Impairment With Mutations at Amino Acid 499 in SPAST , 2018, Journal of child neurology.

[10]  X. Zuo,et al.  Katanin spiral and ring structures shed light on power stroke for microtubule severing , 2017, Nature Structural &Molecular Biology.

[11]  N. Wood,et al.  Truncating mutations in SPAST patients are associated with a high rate of psychiatric comorbidities in hereditary spastic paraplegia , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[12]  E. Magnin,et al.  Cognitive Impairment Involving Social Cognition in SPG4 Hereditary Spastic Paraplegia , 2016, Behavioural neurology.

[13]  Zacharias Kohl,et al.  Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients , 2016, Annals of neurology.

[14]  J. Solowska,et al.  Hereditary spastic paraplegia SPG4: what is known and not known about the disease. , 2015, Brain : a journal of neurology.

[15]  C. Blackstone,et al.  Loss of Spastin Function Results in Disease‐Specific Axonal Defects in Human Pluripotent Stem Cell‐Based Models of Hereditary Spastic Paraplegia , 2014, Stem cells.

[16]  P. Chinnery,et al.  The neurological and ophthalmological manifestations of SPG4-related hereditary spastic paraplegia , 2012, Journal of Neurology.

[17]  Nicholas W. Wood,et al.  A robust model for read count data in exome sequencing experiments and implications for copy number variant calling , 2012, Bioinform..

[18]  P. Mailly,et al.  Microtubule-targeting drugs rescue axonal swellings in cortical neurons from spastin knockout mice , 2012, Disease Models & Mechanisms.

[19]  D. Burke,et al.  Peripheral neuropathy in hereditary spastic paraplegia due to spastin (SPG4) mutation – A neurophysiological study using excitability techniques , 2012, Clinical Neurophysiology.

[20]  H. J. Schelhaas,et al.  Hereditary spastic paraplegia due to SPAST mutations in 151 Dutch patients: new clinical aspects and 27 novel mutations , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  M. Hutchinson,et al.  Dementia in SPG4 hereditary spastic paraplegia , 2009, Neurology.

[22]  M. Shoukier,et al.  Expansion of mutation spectrum, determination of mutation cluster regions and predictive structural classification of SPAST mutations in hereditary spastic paraplegia , 2009, European Journal of Human Genetics.

[23]  B. Brais,et al.  SPG4 Founder Effect in French Canadians with Hereditary Spastic Paraplegia , 2007, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[24]  M. Ruberg,et al.  Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia , 2006, Journal of Medical Genetics.

[25]  G. Gundersen,et al.  Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing , 2005, The Journal of cell biology.

[26]  C. Krarup,et al.  Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation , 2004, European journal of neurology.

[27]  M. Pericak-Vance,et al.  Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations , 2004, Neurogenetics.

[28]  E. Rugarli,et al.  Hereditary spastic paraplegia: clinical genetic study of 15 families. , 2004, Archives of neurology.

[29]  G. Bernardi,et al.  A new SPG4 mutation in a variant form of spastic paraplegia with congenital arachnoid cysts , 2004, Neurology.

[30]  B. Dubois,et al.  Subtle cognitive impairment but no dementia in patients with spastin mutations. , 2003, Archives of neurology.

[31]  E. Rugarli,et al.  Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. , 2002, Human molecular genetics.

[32]  G. Plant,et al.  A large family with hereditary spastic paraparesis due to a frame shift mutation of the spastin (SPG4) gene: association with multiple sclerosis in two affected siblings and epilepsy in other affected family members , 2001, Journal of neurology, neurosurgery, and psychiatry.

[33]  M. Pericak-Vance,et al.  Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. , 2001, American journal of human genetics.

[34]  C. Blackstone.  Hereditary spastic paraplegia. , 2018, Handbook of clinical neurology.

[35]  A. Durr,et al.  Mental deficiency in three families with SPG4 spastic paraplegia , 2008, European Journal of Human Genetics.